BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6320298)

  • 1. Dopaminergic involvement in the control of drinking behaviour: a brief review.
    Dourish CT
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):487-93. PubMed ID: 6320298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of sensorimotor function by dopaminergic nigrostriatal neurons: influence on eating and drinking.
    White NM
    Neurosci Biobehav Rev; 1986; 10(1):15-36. PubMed ID: 3010199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect evidence for a feedback loop mechanism between two central dopaminergic pathways: preliminary results.
    Yehuda S
    Commun Psychopharmacol; 1979; 3(2):115-9. PubMed ID: 467002
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopaminergic involvement in hypothalamic function: extrahypothalamic and hypothalamic control. A neuroanatomical analysis.
    Fuxe K; Goldstein M; Hökfelt T; Jonsson G; Lidbrink P
    Adv Neurol; 1974; 5():405-19. PubMed ID: 4374065
    [No Abstract]   [Full Text] [Related]  

  • 6. Lesions of the superior colliculus in the rat differentiate between nigrostriatal and mesolimbic dopamine systems.
    Dawbarn D; Pycock CJ
    Brain Res; 1982 Mar; 235(1):148-55. PubMed ID: 6892367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral DA receptor blockade facilitates behavioural recovery from nigrostriatal damage.
    Willis GL; Smith GC; Kinchington PC
    Brain Res Bull; 1983 Jul; 11(1):15-9. PubMed ID: 6627037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral characterization of intracranial self-stimulation from mesolimbic, mesocortical, nigrostriatal, hypothalamic and extra-hypothalamic sites in the non-inbred CD-1 mouse strain.
    Zacharko RM; Kasian M; Irwin J; Zalcman S; LaLonde G; MacNeil G; Anisman H
    Behav Brain Res; 1990 Jan; 36(3):251-81. PubMed ID: 2310489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of specific dopamine lesions and dopamine receptor sensitivity on angiotensin II- and carbachol-induced thirst in rats.
    Sumners C; Woodruff GN; Poat JA
    Psychopharmacology (Berl); 1981; 73(2):180-3. PubMed ID: 6785812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain monoaminergic control of male reproductive behavior. II. Dopamine and the post-ejaculatory refractory period.
    McIntosh TK; Barfield RJ
    Behav Brain Res; 1984 Jun; 12(3):267-73. PubMed ID: 6432003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal dopamine-rich grafts and 6-OHDA lesions independently provide partial protection from the adult nigrostriatal lesion syndrome.
    Rogers DC; Dunnett SB
    Behav Brain Res; 1989 Aug; 34(1-2):131-46. PubMed ID: 2504223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesions of the dopaminergic nigrostriatal pathway alter preprosomatostatin messenger RNA levels in the striatum, the entopeduncular nucleus and the lateral hypothalamus of the rat.
    Soghomonian JJ; Chesselet MF
    Neuroscience; 1991; 42(1):49-59. PubMed ID: 1677745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feeding and hypothalamic stimulation increase dopamine turnover in the accumbens.
    Hernandez L; Hoebel BG
    Physiol Behav; 1988; 44(4-5):599-606. PubMed ID: 3237847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways.
    Michelot R; Leviel V; Giorguieff-Chesselet MF; Chéramy A; Glowinski J
    Life Sci; 1979 Feb; 24(8):715-23. PubMed ID: 86931
    [No Abstract]   [Full Text] [Related]  

  • 16. Amine accumulation in behavioural pathology.
    Willis GL; Smith GC
    Brain Res; 1985 Jun; 356(2):109-32. PubMed ID: 3924349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity.
    Grace AA; Bunney BS
    Brain Res; 1985 May; 333(2):271-84. PubMed ID: 2986775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF; Del Fiacco M; Iversen SD
    Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
    [No Abstract]   [Full Text] [Related]  

  • 19. Lesions of the substantia nigra retard Pavlovian eye-blink but not heart rate conditioning in the rabbit.
    Kao KT; Powell DA
    Behav Neurosci; 1988 Aug; 102(4):515-25. PubMed ID: 3166726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motivational versus motor impairment after haloperidol injection or 6-OHDA lesions in the ventral tegmental area or substantia nigra in rats.
    Papp M; Bal A
    Physiol Behav; 1986; 38(6):773-9. PubMed ID: 3103150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.